REDWOOD CITY, CA
Allocation by class
Portfolio Concentration
Top 3 weight
51.4%
Top 10 weight
95.1%
Voting Authority Distribution
Total shares with voting rights: 42.11M
Full voting authority
42.11M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Veradermics, Inc.SOLE | Common Stock | 2.40M | SH | $295.29M 28.42% | 2.40M | 0.00 | 0.00 |
Zenas BioPharma, IncSOLE | Common Stock | 5.04M | SH | $127.86M 12.31% | 5.04M | 0.00 | 0.00 |
CRISPR Therapeutics AGSOLE | Common Shares | 2.04M | SH | $111.19M 10.70% | 2.04M | 0.00 | 0.00 |
Avalyn Pharma, IncSOLE | Common Stock | 3.31M | SH | $108.92M 10.48% | 3.31M | 0.00 | 0.00 |
Design Therapeutics, Inc.SOLE | Common Stock | 6.53M | SH | $94.44M 9.09% | 6.53M | 0.00 | 0.00 |
Odyssey Therapeutics, Inc.SOLE | Common Stock | 3.79M | SH | $71.00M 6.83% | 3.79M | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 1.96M | SH | $55.15M 5.31% | 1.96M | 0.00 | 0.00 |
ORIC Pharmaceuticals, Inc.SOLE | Common Stock | 4.62M | SH | $49.98M 4.81% | 4.62M | 0.00 | 0.00 |
Mineralys Therapeutics Inc.SOLE | Common Stock | 1.56M | SH | $42.20M 4.06% | 1.56M | 0.00 | 0.00 |
ARS Pharmaceuticals, Inc.SOLE | Common Stock | 4.01M | SH | $32.14M 3.09% | 4.01M | 0.00 | 0.00 |
Mobia Medical, IncSOLE | Common Stock | 1.99M | SH | $26.61M 2.56% | 1.99M | 0.00 | 0.00 |
Nkarta, Inc.SOLE | Common Stock | 3.33M | SH | $9.43M 0.91% | 3.33M | 0.00 | 0.00 |
Oculis Holding AGSOLE | Ordinary Shares | 641.02K | SH | $8.89M 0.86% | 641.02K | 0.00 | 0.00 |
Ultragenyx Pharmaceutical Inc.SOLE | Common Stock | 137.75K | SH | $4.60M 0.44% | 137.75K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Shares | 747.75K | SH | $1.29M 0.12% | 747.75K | 0.00 | 0.00 |